Rankings
▼
Calendar
ARQT Q1 2024 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ARQT
Arcutis Biotherapeutics, Inc.
$3B
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$50M
+1682.4% YoY
Gross Profit
$46M
93.4% margin
Operating Income
-$32M
-63.8% margin
Net Income
-$35M
-71.4% margin
EPS (Diluted)
$-0.32
QoQ Revenue Growth
+266.5%
Cash Flow
Operating Cash Flow
-$32M
Free Cash Flow
-$32M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$479M
Total Liabilities
$254M
Stockholders' Equity
$225M
Cash & Equivalents
$191M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$50M
$3M
+1682.4%
Gross Profit
$46M
$2M
+2218.0%
Operating Income
-$32M
-$76M
+58.5%
Net Income
-$35M
-$80M
+55.6%
← FY 2024
All Quarters
Q2 2024 →